People suffering from metabolic diseases could also be at a higher risk for cancers, suggests a new study.
Individuals with late-stage CKM syndrome may be at a 30% higher risk for cancer, according to researchers who published their findings on April 27 in the journal Circulation: Population Health and Outcomes.
In America, 9 out of 10 adults have at least one manifestation of CKM syndrome, including hypertension, elevated cholesterol, high blood sugar levels, obesity, and impaired renal function, according to research presented in the background information section.
Take Control of Your Health Today
Quickly check your symptoms and understand your prescriptions with our smart, easy-to-use AI tools.
The most serious threats posed by CKM syndrome include myocardial infarction and cerebrovascular accident, yet CKM syndrome impacts all vital body systems. As such, it is also associated with kidney dysfunction, dementia, steatosis, and sleep apnea, among other health issues.
According to the researchers at the American Heart Association, the study results showed that the healthy behaviors that ward off heart disease and kidney failure are likely to help protect against cancer.
For those with established cardiovascular risk, the CKM syndrome staging framework may be a useful tool to flag high-risk individuals for potential cancer screenings and evaluations.
For more interesting news and updates on cancer and how medications such as Ivermectin, Mebendazole, and Fenbendazole, follow Medipedia. We help you stay up to date on the latest news and developments in health, medication, and treatment practices.
Disclaimer:
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication or treatment.